An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo:

Dementia Big
The pathological hallmarks of Alzheimer’s disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this approach still remains valid, it has not yet produced clinically meaningful results.

http://ift.tt/29iSmw3